Relationship between QRS duration, left ventricular volumes and prevalence of nonviability in patients with coronary artery disease and severe left ventricular dysfunction

European Journal of Heart Failure

Volumn 8, Issue 3, 2006, Pages 275-277

  De Winter, Olivier ^a   Van de Veire, Nico ^a   Van Heuverswijn, Frederic ^a   Van Pottelberge, Geert ^a   Gillebert, Thierry C ^a   De Sutter, Johan ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiac resynchronization therapy; Left ventricular ejection fraction; QRS duration

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE PERFUSION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QRS COMPLEX; STATISTICAL SIGNIFICANCE;

EID: 33747802453     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.10.001     Document Type: Article

References (11)

1. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
2. Leclercq C., and Hare J.M. Ventricular resynchronization. Current state of the art. Circulation 109 (2004) 296-299
3. Bax J.J., Ansalone G., Breithardt O.A., et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 44 (2004) 1-9
4. De Winter O., De Bondt P., Van de Wiele C., De Backer G., Dierckx R.A., and De Sutter J. Day-to-day variability of global left ventricular functional and perfusional measurements by quantitative gated SPECT using Tc-99m tetrofosmin in patients with heart failure due to coronary artery disease. J Nucl Cardiol 11 (2004) 47-52
5. Berman D., and Germano G. An approach to the interpretation and reporting of gated myocardial perfusion SPECT. In: Germano G., and Berman D. (Eds). Clinical Gated Cardiac SPECT (1999), Futura Publishing Company, Inc., New York 147-182
6. Acampa W., Cuocolo A., Petretta M., et al. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy. J Nucl Cardiol 9 (2002) 33-40
7. Koga Y., Wada T., Toshima H., Akazawa K., and Nose Y. Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy. Heart Vessels 8 (1993) 37-41
8. Wilensky R.L., Yudelman P., Cohen A.I., et al. Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy. Am J Cardiol 62 (1988) 276-283
9. Xiao H.B., Roy C., Fujimoto S., and Gibson D.G. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 53 (1996) 163-170
10. Lambiase P.D., Rinaldi A., Hauck J., et al. Non-contact left ventricular endocardial mapping in cardiac resynchronisation therapy. Heart 90 (2004) 44-51
11. Sciagra R., Giaccardi M., Porciani M.C., et al. Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med 45 (2004) 164-168